The Immunex Alumni: Where Are They Now?

Doug Cerretti, president and chief scientific officer, CellCyte Genetics

Caroline Chan, director of human resources, Amgen [Added: 2:40 pm, 1/3/11]

Jean Chin, fiscal specialist 2, UW Medical Center

Wilson Chin, research scientist, University of Washington

Carter Clanton, regional business director, Eisai

Bill Clark, manager of metrology and calibration, Dendreon

Howard Clarke, principal development scientist, CMC Icos Biologics

Stephen Cole, systems engineering manager, Symantec [Added: 4:35 pm, 1/6/11]

Helen Cooke, managing director, Cooke Consulting Group [Added: 7:40 pm, 1/12/11]

Kerri Copp, QC senior supervisor, Genentech

David Cosman, board member of Aequus BioPharma, Sustainable Path Foundation and Earth Economics. [Updated: 10:15 am, 11/16/11]

Tom Cox, senior associate scientist, Novo Nordisk [Added: 9:20 pm, 1/4/11]

Vickie Craig, biotechnology professional

Kirby Cramer, chairman emeritus, SonoSite [Added: 9:35 pm, 1/11/11]

Bruce Creaner, operations manager, Dell

Alexis Cunningham, CRA, Abbott Laboratories

Connie Cunningham, real estate agent

Thomas O. Daniel, president of research, Celgene

Kim Davis, marketing manager, Seattle Children’s Hospital

Terri Davis-Smith, researcher, Bastyr University Research Institute

Peter de Vries, associate director of translational science, Ikaria

Mike Deeley, consultant, Somerset Consulting

Tracy Deisher, founder, research and development director, AVM Biotech

Michael DeJardin, business systems analyst, Fred Hutchinson Cancer Research Center

Alison Del Vento, director of drug safety, Dendreon

Joe Denton, supervisor, QA contract manufacturing, Dendreon

Jonathan Derry, director of research, Sage Bionetworks

Tim Dickenson, system manager, talent stewardship, Providence Health & Services

Marijune Doniego, clinical contracts and finance associate, Gilead Sciences

Bill Dougall, scientist, Amgen

Valoree Dowell, national news specialist, University of Utah

David Drajeske, principal, Biotech BD Consulting

Bob DuBose, executive director, R&D informatics, Amgen

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.